The Effect of Subsyndromal Symptoms of Depression and White Matter Lesions on Disability for Individuals with Mild Cognitive Impairment
Year: 2013
Type: article
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Alzheimer's Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Novartis, Roche, Medpace, Synarc, Alzheimer's Disease Neuroimaging Initiative, Northern California Institute for Research and Education, Elan, Eisai, National Institutes of Health, U.S. Food and Drug Administration, Genentech, University of California, Los Angeles, University of California, San Diego, University of California, San Francisco, National Institute on Aging, National Institute of Mental Health, National Center for Research Resources
Awards: UC Davis Alzheimer's Disease Core Center, G2835601961, G29951154, G3218891203, G3870774570, G3966393351, "MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies", Cognitive and Neuroimaging Predictors of Disability in Late Life Depression, G4196769506, Resource for MRI of Neurodegenerative Disorders, Alzheimer's Disease Neuroimaging Initiative, G9000122335, Alzheimer's Disease Neuroimaging Initiative (ADNI4)
OpenAlex ID: W1966915078
